GLP-1 receptor agonists are widely prescribed for weight management and blood sugar control. NextGen PGx pharmacogenomic testing reports genetic variants that have been studied for possible relevance to how the body processes certain medications in this category.
Response to GLP-1 medications varies from person to person. While diet, activity, dose, and consistency all play a major role, researchers continue to study whether certain genetic variants are associated with differences in medication metabolism.
A PGx test does not predict weight loss outcomes or determine the right dose — it provides additional genetic context that you can discuss with your prescriber alongside your full health history.
Explore genetic testing focused on a specific medication category: semaglutide, tirzepatide, or weight loss medications generally.
Order your NextGen PGx PGx test today and get a unique patient ID in minutes.
Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers. NextGen PGx is not affiliated with, sponsored by, or endorsed by these companies.